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4. Behavioural support - eg. physical activity, dietary change, coping skills for managing the emotional 
demands of living with a chronic illness 
Analysis of studies considered: theoretical basis, background of providers, program format and intensity, 
duration of follow-up, characteristics of participants and generalisability of outcomes. Due to heterogeneity of 
interventions and outcome variables, a narrative synthesis was employed to address the research questions. 
There were fewer studies of diabetes and CAD SME programs that met the inclusion criteria than for asthma, 
and overall, few targeted disadvantaged or culturally diverse populations. Participation favoured better 
educated, Caucasian, females with lower morbidity. Final results and conclusions regarding effectiveness and 
generalisability will be reported. 
This research/project was funded by the State of Victoria through its Department of Human Services (DHS). 
The views and conclusions are those of the authors and do not necessarily represent those of DHS. 
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Success of Disease Management Programs In Community Pharmacy- Asthma 
Presenter: Prof Carol Armour, Pharmacy Faculty, University of Sydney and community 
pharmacy specialist in Guild Asthma Program NSW 
Background: Many pharmacy-based programs have been developed which have shown improved asthma care. 
However, to be sustainable these programs should follow national best practice guidelines and take into 
account the needs of local practitioners. 
Aims: To develop a national clinical service (the Pharmacy Asthma Care Program- PACP) based on Australian 
National Clinical Guidelines, taking into account practitioners' needs and involving patients in goal-setting to 
improve their management of asthma . To evaluate the service. 
Methods: A multi-site, randomised control-versus-intervention, repeated measures design was implemented in 
50 pharmacies (24 control and 26 intervention) across three states in Australia. The PACP service for 
intervention patients involved a cycle of assessment, goal setting and monitoring over six months and followed 
the National Asthma Council 6-step Asthma Management plan. Over 3-4 visits, asthma severity, spirometry, 
inhaler technique, medications and lifestyle issues were reviewed and interventions delivered. Patients were 
referred to their physician for an action plan or other issues when required. Control patients were assessed 
for asthma severity and spirometry at 0 and 6 months, and received no interventions beyond standard patient 
care. Economic, clinical, and humanistic outcomes were used to evaluate the service. 
Results: A total of 351 patients ( 165 intervention and 186 control) completed the study and of these, 80% 
were referred to their physician at least once. On average, patients set three goals for themselves (the 
majority related to medication) and only 9% of patients reported not achieving their goals. There were 
significant (p<O.OS) changes over time in the intervention patients compared to control patients for several 
parameters. In the intervention group, there was a decrease in the proportion of those with severe asthma 
(88% to 53%); an increase in those classified as adherent to preventer medications (54% to 71 %); a decrease in 
salbutamol use; improved quality of life, asthma knowledge and perceived asthma control scores; an increase 
in those having correct inhaler technique (24% to 73%) and an asthma action plan (23% to 64%). The PACP 
was highly cost-effective when compared to other funded programs in Australia. 
Conclusion: The National PACP implemented by community pharmacists has changed the way patients are 
managed in Pharmacy with significant clinical and humanistic benefits for asthma patients, and economic 
benefits for the health care system. 
Acknowledgements: The Pharmacists who were so enthusiastic and supportive. This project was funded by 
the Australian Government Department of Health and Ageing as part of the Third Community Pharmacy 
Agreement. 
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Who benefits most from participating in chronic disease management programs? 
Presenter: Ms Sandra Nolte, Collaborative Institute Research, Consulting and Learning in 
Evaluation, RMIT Uni & AFV Centre for Rheumatic Diseases, Uni of Melbourne 
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Objectives: To quantify the benefits that people receive from participating in self-management courses and 
identify subgroups that benefit most. 
23 
Research Design: People with a wide range of chronic conditions attending self-management courses (N= I ,341 
individuals) were administered the generic Health Education Impact Questionnaire (HEI-Q). Data were 
collected before the first session (baseline) and at the end of courses (follow-up) resulting in 842 complete 
responses. The median (interquartile range) age was 64 (54 to 73) years and most participants were female 
(75%). Outcomes were categorized as Substantial improvement (Effect Size, ES 2: 0.5), Minimal/No change (ES 
-0.49 to 0.49) and Substantial decline (ES =:;; -0.5). 
Results: On average, one third of participants reported substantial benefits after attending a self-management 
course. Proportions of participants reporting substantial benefits ranged from 49% in Skill and technique 
acquisition to 27% in Health service navigation. Stratification by gender, age and education showed that 
younger participants were more likely to benefit, particularly young women. No further subgroup differences 
were observed. 
Conclusions: Given that the health of people with chronic diseases tends to decline, this evaluation is 
reassuring in that about one third of participants coming from a wide range of backgrounds receive substantial 
improvements in their self-management skills. 
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Smoking Cessation - Pharmacy 
Presenter: Ms ..Bnny Bergin, Chief Pharmacist, The Pharmacy Guild of Australia and 
community pharmacist specialist smoking cessation programs N SW 
The Pharmacy Guild of Australia conducted the Quit Smoking Project to implement an effective quit smoking 
management program in community pharmacy. The Guild received funding from the Australian Government 
Department of Health and Ageing as part of the Third Community Pharmacy Agreement, in recognition of the 
important role pharmacies play in the Nicotine Replacement Therapy (NRT) category. 
The aim of the project was to: 
• Demonstrate an increase in the number of consumers undertaking smoking cessation strategies; 
• Assist those consumers to successfully quit smoking with the use of retail navigation display boards 
(stands) on smoking cessation products, quit plans and referral services, and by providing ongoing advice 
and support; and 
• Evaluate the program's impact and effectiveness in assisting those consumers to quit smoking. 
A major component of the project was online training on the Quit Smoking Program for pharmacists and 
pharmacy assistants. 
The project compared intervention and control group pharmacies. Key findings showed that customers who 
visited an intervention pharmacy and purchased NRT: 
• Received more useful advice and written information; 
• Were more likely to have been informed of support services; and 
• Were more likely to have completed the NRT program. 
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Chronic Disease Self Management programs- what is the evidence? 
Presenter: MsSharan Ermel, Research Assistant, Collaborative Health, Education and 
Research Centre (CHERC) Bendigo Health Care Group VIC 
Background: In Australia, chronic disease self-management is a burgeoning area of health care due to the 
increasing incidence of chronic disease and the depleting health dollars available to meet the needs of 
Australians 1• It is envisaged that to ease the increasing burden of chronic disease, not only on the health care 
system but also on the individual living with chronic disease, self-management activity and commitment must 
increase2• 
Methods: An extensive review of the literature published between 2000 to mid 2005 was undertaken to 
identify and classify the range of chronic disease self-management programs available. The Cochrane, Medline, 
Pre-Medline, CINAHL, Psych Info and Journals@Ovid databases were searched using combinations of 
keywords, in conjunction with additional hand searching of relevant citations and journals. Relevant study 
results were graded according to Levels of Evidence outlined by the National Breast Cancer Centre 
Psychosocial working group, which were based on the earlier framework of the National Health & Medical 
Research Council 3 
Results: Over 1500 potential studies were identified through this process. Through adherence to a strict 
inclusion criterion, the number of included papers was reduced to 46 papers detailing 44 studies of chronic 
disease self-management programs or models. The studies identified within this literature review dealt with a 
wide range of self-management interventions. These ranged from programs and interventions developed for, 
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